It may be possible to interrupt the transmission of soil-transmitted helminths, which affect nearly 2 billion individuals globally. Here, the authors give an overview of the DeWorm3 project, which aims to test the feasibility of interrupting soil-transmitted helminth transmission.
Browsing: Clinical > Outcomes Research
In this interview, Roy Anderson, Director for the London Centre for Neglected Tropical Disease Research speaks about the work undertaken by the Centre and gives his thoughts on the wider NTD field.
Martin Olivier, discusses how the nanobiome of vectors may impact the infectious processes of disease, highlighting his work on exosomes in sandflies and leishmaniasis.
The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries. In this research article, the authors carry out a multi-country case study investigating the the adoption and use of HPV vaccines.
Researchers have quantified the burden of stigmatization and discrimination on lymphatic filariasis patients, discovering individuals are up to four times more likely to suffer depression than average.
Recent studies suggest that the risk of a heart attack could be increased 17-fold during the 7 days after a respiratory infection.
Reporting from ECCMID17, we spoke to William Irving about his current work on hepatitis C and his thoughts on the future of this field.
Researchers examining post-Ebola syndrome have discovered ocular consequences, including a disease-associated retinal scar.
Genotyping hepatitis C patients with advanced cirrhosis could help predict improvement after treatment, according to research presented at Digestive Disease Week®.